Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
national top stories
66
×
startups
66
×
life sciences
boston blog main
san francisco blog main
biotech
boston top stories
new york blog main
texas blog main
deals
texas top stories
san diego blog main
new york top stories
wisconsin blog main
san diego top stories
san francisco top stories
detroit blog main
vc
wisconsin top stories
detroit top stories
raleigh-durham blog main
seattle blog main
venture capital
cancer
fda
national
raleigh-durham top stories
software
boulder/denver blog main
indiana blog main
innovation
seattle top stories
boulder/denver top stories
indiana top stories
clinical trials
medical devices
funding
people
investing
What
roundup
bio
new
drug
medicines
startup
innovation
latest
medical
million
news
based
tech
texas
announced
company
drugs
let’s
technology
tx
ceo
companies
deal
raised
raises
therapeutics
years
biotech
cancer
today
capital
catch
caught
digital
healthcare
life
software
better
big
biggest
Language
unset
unknown
Current search:
startups
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
4 years ago
HAP Partners With Livongo on Tech-Enabled Diabetes Compliance Program
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Chevron Tech, Medical Informatics, ActivTrak, Linear & More TX Tech
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
5 years ago
AgileCraft’s Exit, $45M for Ojo Labs, Intel Grants & More TX Tech
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
DermaClip Ramps Up for U.S. Sales Push of Wound-Healing Device
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
GrainChain, Chargify, Q2, Hypergiant, NASA Tech & More TX Tech
@xconomy.com
5 years ago
ResMed Boosts Connected Health Play With $225M Propeller Health Deal
@xconomy.com
5 years ago
Shine Raises $30M, Could Add $150M More After Inking Deerfield Deal
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Nominations Open for San Diego’s Inaugural Xconomy Awards
@xconomy.com
5 years ago
Sam’s Club Goes Digital, BNSF’s Electric Locomotive, & More TX Tech
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
@xconomy.com
5 years ago
Upland Software, Bumble in India, Cratejoy Layoffs, & More TX Tech
First
Prev
Page 1
(current)
Next
Last